<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"> 
<ArticleSet> 
     <Article> 
          <Journal> 
           <PublisherName>Academy of Medical Sciences of Islamic Republic of Iran</PublisherName> 
            <JournalTitle>Archives of Iranian Medicine</JournalTitle> 
            <Issn>1029-2977</Issn> 
            <Volume>13</Volume> 
            <Issue>4</Issue> 
            <PubDate> 
              <Year>2010</Year> 
              <Month>7</Month> 
              <Day>1</Day> 
            </PubDate> 
          </Journal> 
          <ArticleTitle>Methylprednisolone Acetate Injection Plus Casting Versus Casting Alone for the Treatment of de Quervain’s Tenosynovitis</ArticleTitle> 
          <FirstPage></FirstPage> 
          <LastPage></LastPage> 
          <Language>EN</Language> 
          <AuthorList><Author> 
<FirstName>Seyed Abdolhossein </FirstName> 
<MiddleName></MiddleName> 
<LastName>Mehdinasab </LastName> 
<Suffix></Suffix> 
<Affiliation>Department of Orthopedic Surgery, Imam Khomeini Hospital, Jondishapur University of Medical Sciences,Ahwaz, Iran.</Affiliation> 
</Author><Author> 
<FirstName>Seyed Amirmohammad </FirstName> 
<MiddleName></MiddleName> 
<LastName>Alemohammad </LastName> 
<Suffix></Suffix> 
<Affiliation>Department of Orthopedic Surgery, Aria Hospital, Ahwaz, Iran</Affiliation> 
</Author></AuthorList> 
          <ArticleIdList> 
            <ArticleId IdType="pii"></ArticleId> 
            <ArticleId IdType="doi"></ArticleId> 
          </ArticleIdList> 
          <Abstract>
            BACKGROUND: There is no consensus in the treatment of de  Quervain's tenosynovitis, but wrist support with or without local corticosteroid  injection has been considered as an effective treatment modality. Some patients  have expressed reluctance for steroid injections because of the fear of probable  adverse reactions. This study was performed to compare the outcome of  methylprednisolone acetate injection plus thumb spica cast versus cast alone for  the treatment of de Quervain's tenosynovitis. METHODS: This randomized  prospective study was conducted from January 2005 to July 2008 in the orthopedic  clinics of our hospital and private offices. A total of 73 patients with de  Quervain's tenosynovitis were managed with either of these methods: 1) injection  of methylpredmisolone acetate in the first dorsal compartment of the wrist  followed by wrist thumb spica cast. 2) casting alone. Wrist casting duration in  both groups was one month and the patients were followed for 6 months.RESULTS:  In the first group, a total of 37 patients were included (injection plus wrist  immobilization by cast), and 36 patients in the second group (wrist casting  alone). The mean age was 32.6 years (21 &ndash; 61 years) in all patients. There were  63 women and 10 men. Overall success rate was 86.5% in the first and 36.1% in  the second groups, with a significant difference for both groups with respect to  pain score and cure rate (P&lt;0.05). Temporary pain was the most common adverse  reaction at the site of injection and was noted in 40% of patients. Despite this  adverse reaction which was related to methylprednisolone injection, a higher  success rate was seen in the injection group in comparison to patients treated  solely by casting.CONCLUSION: Support of the wrist with casting alone had less  favorable outcome in de Quervain's tenosynovitis. Adding methylprednisolone  acetate injection into the first dorsal compartment of the wrist is necessary  for more optimal results.
          </Abstract> 
        </Article> 
   
      </ArticleSet>
